345 related articles for article (PubMed ID: 22945571)
1. Nanomaterials: a challenge for toxicological risk assessment?
Haase A; Tentschert J; Luch A
Exp Suppl; 2012; 101():219-50. PubMed ID: 22945571
[TBL] [Abstract][Full Text] [Related]
2. Historical overview of nanotechnology and nanotoxicology.
Santamaria A
Methods Mol Biol; 2012; 926():1-12. PubMed ID: 22975953
[TBL] [Abstract][Full Text] [Related]
3. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.
Som C; Nowack B; Krug HF; Wick P
Acc Chem Res; 2013 Mar; 46(3):863-72. PubMed ID: 23110540
[TBL] [Abstract][Full Text] [Related]
4. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
[TBL] [Abstract][Full Text] [Related]
5. Health effects of nanomaterials.
Tetley TD
Biochem Soc Trans; 2007 Jun; 35(Pt 3):527-31. PubMed ID: 17511644
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in cosmetics.
Katz LM; Dewan K; Bronaugh RL
Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
[TBL] [Abstract][Full Text] [Related]
7. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
Thomas K; Sayre P
Toxicol Sci; 2005 Oct; 87(2):316-21. PubMed ID: 16049265
[TBL] [Abstract][Full Text] [Related]
8. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.
Nel A; Xia T; Meng H; Wang X; Lin S; Ji Z; Zhang H
Acc Chem Res; 2013 Mar; 46(3):607-21. PubMed ID: 22676423
[TBL] [Abstract][Full Text] [Related]
10. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future.
Powell MC; Kanarek MS
WMJ; 2006 May; 105(3):18-23. PubMed ID: 16749320
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterials: certain aspects of application, risk assessment and risk communication.
Laux P; Tentschert J; Riebeling C; Braeuning A; Creutzenberg O; Epp A; Fessard V; Haas KH; Haase A; Hund-Rinke K; Jakubowski N; Kearns P; Lampen A; Rauscher H; Schoonjans R; Störmer A; Thielmann A; Mühle U; Luch A
Arch Toxicol; 2018 Jan; 92(1):121-141. PubMed ID: 29273819
[TBL] [Abstract][Full Text] [Related]
13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
14. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
15. Nanomaterial health effects--part 1: background and current knowledge.
Powell MC; Kanarek MS
WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
[TBL] [Abstract][Full Text] [Related]
16. [Nanomaterials in foodstuffs - toxicological properties and risk assessment].
Böhmert L; Laux P; Luch A; Braeuning A; Lampen A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Jul; 60(7):722-727. PubMed ID: 28516262
[TBL] [Abstract][Full Text] [Related]
17. Environmental and health effects of nanomaterials in nanotextiles and façade coatings.
Som C; Wick P; Krug H; Nowack B
Environ Int; 2011 Aug; 37(6):1131-42. PubMed ID: 21397331
[TBL] [Abstract][Full Text] [Related]
18. Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review.
Tyner K; Sadrieh N
Methods Mol Biol; 2011; 697():17-31. PubMed ID: 21116951
[TBL] [Abstract][Full Text] [Related]
19. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterials in food contact materials; considerations for risk assessment.
Ćwiek-Ludwicka K; Ludwicki JK
Rocz Panstw Zakl Hig; 2017; 68(4):321-329. PubMed ID: 29264907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
